Table 1 Patient and tumor characteristics at baseline
No. of patients | Percent | |
|---|---|---|
Total | 177 | 100 |
Menopausal status at diagnosis | ||
Premenopausal | 77 | 43.5 |
Postmenopausal | 100 | 56.5 |
Pathological tumor size | ||
T 1 | 99 | 55.9 |
T 2 | 58 | 32.8 |
T 3 | 10 | 5.6 |
T 4 | 10 | 5.6 |
Pathological nodal status | ||
N 0 | 95 | 53.7 |
N 1 | 46 | 26.0 |
N 2 | 23 | 13.0 |
N 3 | 9 | 5.1 |
Not evaluated | 4 | 2.3 |
Pathological stage | ||
I | 63 | 35.6 |
II A | 55 | 31.1 |
II B | 22 | 12.4 |
III A | 14 | 7.9 |
III B | 10 | 5.6 |
III C | 9 | 5.1 |
Not evaluated | 4 | 2.3 |
Type of surgery | ||
Breast-conserving surgery | 147 | 83.1 |
Mastectomy | 30 | 16.9 |
Axillary management | ||
Sentinel lymph node biopsy alone | 95 | 53.7 |
Axillary lymph node dissection | 79 | 44.6 |
No surgery | 3 | 1.7 |
Histological grade | ||
1 | 41 | 23.2 |
2 | 67 | 37.9 |
3 | 69 | 39.0 |
Adjuvant Chemotherapy | ||
Yes | 70 | 39.5 |
No | 107 | 60.5 |
Adjuvant Endocrine therapy | ||
Yes | 146 | 82.5 |
No | 31 | 17.5 |